Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
3.100
-0.080 (-2.52%)
At close: Nov 22, 2024, 4:00 PM
3.080
-0.020 (-0.65%)
After-hours: Nov 22, 2024, 5:46 PM EST
Pasithea Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | 0.02 | - |
| Cost of Revenue | - | - | - | 0.02 | - |
| Gross Profit | - | - | - | -0 | - |
| Selling, General & Admin | 7.1 | 7.88 | 9.92 | 4.51 | 0.06 |
| Research & Development | 9.04 | 8.1 | 2.67 | - | - |
| Operating Expenses | 16.14 | 15.98 | 12.59 | 4.51 | 0.06 |
| Operating Income | -16.14 | -15.98 | -12.59 | -4.51 | -0.06 |
| Interest Expense | - | - | - | -0 | - |
| Interest & Investment Income | 0.52 | 0.42 | - | - | - |
| Other Non Operating Income (Expenses) | -0.13 | 0.06 | 1.85 | 2.33 | - |
| EBT Excluding Unusual Items | -15.76 | -15.51 | -10.74 | -2.17 | -0.06 |
| Legal Settlements | - | - | -1 | - | - |
| Other Unusual Items | - | - | 0.01 | - | - |
| Pretax Income | -15.76 | -15.51 | -11.73 | -2.17 | -0.06 |
| Earnings From Continuing Operations | -15.76 | -15.51 | -11.73 | -2.17 | -0.06 |
| Earnings From Discontinued Operations | -0.02 | -0.45 | -2.21 | - | - |
| Net Income | -15.78 | -15.96 | -13.94 | -2.17 | -0.06 |
| Net Income to Common | -15.78 | -15.96 | -13.94 | -2.17 | -0.06 |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 |
| Shares Change (YoY) | -20.66% | -2.83% | 142.65% | 41.29% | - |
| EPS (Basic) | -15.14 | -13.01 | -11.04 | -4.18 | - |
| EPS (Diluted) | -15.14 | -13.01 | -11.04 | -4.18 | - |
| Free Cash Flow | -15.39 | -13.46 | -13.8 | -3.2 | -0.06 |
| Free Cash Flow Per Share | -14.76 | -10.97 | -10.93 | -6.14 | -0.16 |
| Gross Margin | - | - | - | -14.69% | - |
| Operating Margin | - | - | - | -29925.73% | - |
| Profit Margin | - | - | - | -14430.49% | - |
| Free Cash Flow Margin | - | - | - | -21216.05% | - |
| EBITDA | -15.49 | -15.33 | -12.58 | -4.51 | - |
| D&A For EBITDA | 0.65 | 0.65 | 0.01 | 0 | - |
| EBIT | -16.14 | -15.98 | -12.59 | -4.51 | -0.06 |
Source: S&P Capital IQ. Standard template.
Financial Sources.